# Kisspeptin FAQ: Mechanism, Testosterone, Fertility & Isoforms

> Kisspeptin FAQ — direct, cited answers on the KISS1R mechanism, testosterone and LH effects, fertility and IVF, the KP-10 vs KP-54 isoforms, and the half-life.

Direct, cited answers to the questions people actually ask about kisspeptin.

## What is kisspeptin?

Kisspeptin is the KISS1 gene product and a KISS1R/GPR54 agonist — a reproductive neuropeptide that is the principal upstream activator of GnRH neurons. Loss-of-function GPR54 mutations cause failure of puberty in humans, and Gpr54-knockout mice reproduce that phenotype, establishing the signal as essential for reproductive maturation [1]. It acts one rung above the sex hormones, not as a hormone itself.

## What is kisspeptin used for in research?

In supervised research, kisspeptin is studied to trigger oocyte maturation in IVF without causing OHSS [5], to restore LH pulses in women with hypothalamic amenorrhea [4], and to probe sexual-desire brain circuits. A systematic review identified 29 interventional trials across amenorrhea, puberty, ovarian function, and fertility regulation [7]. No use is regulatory-approved; all of it is investigational.

## What receptor does kisspeptin bind?

Kisspeptin binds KISS1R, formerly called GPR54 — a Gq/11-coupled G-protein-coupled receptor on hypothalamic GnRH neurons. Loss-of-function mutations in this receptor cause hypogonadotropic hypogonadism and failure of puberty [1], and kisspeptin fails to stimulate LH or FSH in Gpr54-knockout mice, confirming the receptor as the obligatory control point [13].

## How does kisspeptin work in the body?

Kisspeptin docks on KISS1R on GnRH neurons, triggering a phospholipase C / IP3 / calcium cascade that depolarizes the neuron and drives pulsatile GnRH release [2]. GnRH then stimulates pituitary LH and FSH secretion, which drives the gonads to make sex steroids. It is the upstream switch of the hypothalamic-pituitary-gonadal axis — it does not supply any hormone directly.

## What is the mechanism by which kisspeptin-10 exerts its effects?

Kisspeptin-10 binds KISS1R and excites GnRH neurons through the same Gq/11 / PLC / IP3 / calcium pathway that closes potassium channels and opens cation channels, depolarizing the cell [2]. In healthy men, an intravenous KP-10 bolus drove LH from 4.1 to 12.4 IU/L within 30 minutes [3]. Its effect is short because plasma peptidases clear KP-10 within minutes.

## What are KNDy neurons and how do they relate to kisspeptin?

KNDy neurons are arcuate-nucleus neurons that co-express Kisspeptin, Neurokinin B, and Dynorphin, and they are thought to act as the GnRH pulse generator. In ewes, neurokinin B signaling initiates synchronized activity, dynorphin terminates each burst, and kisspeptin relays the output to GnRH neurons [8]. This model is regarded as the mammalian pulse generator controlling reproduction [9].

## What does kisspeptin do?

Kisspeptin starts the reproductive cascade: it fires GnRH neurons, which trigger pituitary LH and FSH, which drive the gonads to make sex steroids. It was discovered because losing its receptor blocks puberty entirely [1]. In studies it raises LH, FSH, and testosterone in men [16], restores cycles in hypothalamic amenorrhea [4], and triggers ovulation in IVF [5].

## Does kisspeptin increase testosterone?

Yes, indirectly, in studied populations. In healthy men, a continuous intravenous kisspeptin-10 infusion at 4 ug/kg/h raised serum testosterone from 16.6 to 24.0 nmol/L by stimulating LH, which signals the testes to produce testosterone [3]. Kisspeptin does not supply testosterone itself; it acts upstream on the GnRH neurons that ultimately drive its production.

## How much does kisspeptin increase testosterone?

In one healthy-men study, continuous intravenous kisspeptin-10 at 4 ug/kg/h raised serum testosterone from 16.6 to 24.0 nmol/L, alongside a rise in LH and LH pulse frequency [3]. This is a single research finding at a stated dose and route in healthy men, not a general or reproducible human-use figure, and it is not a dosing recommendation.

## Can kisspeptin help with fertility?

In research, yes — as an IVF trigger. In a Phase 2 trial of 60 women at high OHSS risk, a single subcutaneous kisspeptin-54 dose (3.2-12.8 nmol/kg) matured oocytes in 95% of women with no case of moderate, severe, or critical OHSS, and the highest live-birth rate (62%) followed the 9.6 nmol/kg dose [5]. It remains investigational and unapproved for fertility use.

## Can kisspeptin restore ovulation in women with hypothalamic amenorrhea?

In supervised research it restored LH pulsatility, a prerequisite for ovulation. Continuous intravenous kisspeptin-54 (0.01-1.00 nmol/kg/h) raised LH pulses from 1.6 to 5.0 per 8 hours (~3-fold) and pulse secretory mass about 6-fold versus vehicle in women with hypothalamic amenorrhea [4]. The highest dose, however, produced tachyphylaxis over the infusion. It is investigational, not an approved treatment.

## What is the difference between kisspeptin-10 and kisspeptin-54?

Both are isoforms of the same molecule sharing the receptor-binding RF-amide tail, but they differ in length and duration. Kisspeptin-54 (KP-54, originally metastin) is the 54-residue form with a human half-life of about 27-28 minutes; kisspeptin-10 (KP-10) is the short decapeptide cleared within roughly 4 minutes [3]. KP-54 carries most multi-hour clinical applications; KP-10 suits short pharmacological challenges.

## What is the KISS1 gene?

KISS1 is the gene on chromosome 1q32 that encodes the kisspeptin precursor, which is cleaved into kisspeptin-54 and shorter fragments. It was first identified in 1996 as a metastasis-suppressor gene in melanoma before its reproductive role was known. Loss-of-function mutations in its receptor (GPR54/KISS1R) cause failure of puberty, defining KISS1 signaling as essential for reproduction [1].

## What is metastin and how does it relate to kisspeptin?

Metastin is the original name for kisspeptin-54, given when KISS1 was identified as a metastasis-suppressor gene. The terms are used interchangeably: metastin and kisspeptin-54 (KP-54) refer to the same 54-amino-acid isoform. The name reflects the gene's first-discovered role in suppressing tumor spread, which preceded the discovery that the peptide is the master switch of the reproductive axis [1].

## How was kisspeptin discovered?

KISS1 was discovered in 1996 as a metastasis-suppressor gene in human melanoma and named for Hershey, Pennsylvania. Its orphan receptor GPR54 was deorphanized around 2001, and in 2003 two groups independently showed that loss-of-function GPR54 mutations cause hypogonadotropic hypogonadism and failure of puberty — reframing kisspeptin as the master upstream switch of the reproductive axis [1].

## How long does kisspeptin take to work?

Quickly, on the hormone readouts. In healthy men, an intravenous kisspeptin-10 bolus drove LH from 4.1 to 12.4 IU/L within 30 minutes [3], and in the 2025 intranasal study LH rose rapidly after dosing [6]. These are acute hormonal responses measured in minutes to an hour; they are research findings, not a guide to any personal effect or timeline.

## What is the half-life of kisspeptin?

It depends on the isoform. Kisspeptin-10 has a functional half-life of about 4 minutes in humans, cleared rapidly by plasma peptidases; kisspeptin-54 lasts much longer, about 27-28 minutes (27.6 +/- 1.1 minutes reported in early work), because its larger size resists endopeptidase cleavage [3]. That gap explains why KP-54 carries the longer clinical applications.

## How does stress suppress kisspeptin and disrupt the reproductive axis?

Hypothalamic amenorrhea — loss of periods from low body weight, heavy exercise, or stress — is associated with reduced kisspeptin-neuron activity and suppressed GnRH pulsatility. In affected women, supplying kisspeptin-54 restored LH pulses roughly threefold versus vehicle, indicating the axis was quietened upstream rather than broken [4]. This positions reduced kisspeptin signaling as a plausible link between stress and a stalled reproductive axis.

## How does kisspeptin reduce OHSS risk compared to hCG as an IVF trigger?

Conventional IVF triggers can over-stimulate the ovaries and cause OHSS, a potentially serious complication. Kisspeptin-54 instead triggers the body's own short-lived LH surge through the natural GnRH pathway: in 60 high-risk women, a single subcutaneous dose matured oocytes in 95% with no case of moderate, severe, or critical OHSS [5]. The self-limiting surge is the proposed safety advantage.

## Can kisspeptin-54 trigger ovulation more safely than GnRH agonists in IVF?

In research, kisspeptin-54 triggered oocyte maturation in 95% of high-OHSS-risk women with zero cases of moderate-to-critical OHSS and a 62% live-birth rate at the 9.6 nmol/kg dose [5]. By acting upstream to evoke a physiological LH surge, it is being studied as a gentler trigger, but it remains investigational and is not an approved alternative to any standard trigger.

## Does kisspeptin help with hypothalamic amenorrhea?

In supervised studies it restored the missing hormonal pulses. Continuous intravenous kisspeptin-54 raised LH pulses from 1.6 to 5.0 per 8 hours and pulse secretory mass about 6-fold versus vehicle in women with hypothalamic amenorrhea [4]. High doses produced tachyphylaxis, so spacing matters. It is an investigational research finding, not an approved treatment for the condition.

## Why does kisspeptin-54 produce longer-lasting LH release than kisspeptin-10?

Kisspeptin-54 is larger and more resistant to the endopeptidases that rapidly cleave kisspeptin-10, giving it a human half-life of about 27-28 minutes versus roughly 4 minutes for KP-10 [3]. The longer circulating presence sustains receptor engagement and so a longer LH response. In the 2025 intranasal study, KP-54 stimulated LH across all three groups tested [6].

---

An instrument-precise reading of the kisspeptin literature, logged study by study with the KISS1R-agonist mechanism and the investigational status held in plain view — no clinic behind the console and nothing here dosed, prescribed, or sold.